QGEN

#951
QIAGEN N.V.
42.09 USD
+0.38%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
42.03
42.12
Year Range
38.80
57.82
Daily Change
+0.38%
Monthly Change
+2.23%
6 month change
-11.30%
Year Change
-0.12%
Previous Close
41.93
Open
42.03
Bid
Ask
Low
42.03
High
42.12
Volume
150
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 9.13 B
  • Employee 5 654
  • Founded 1984
  • CEO Thierry Bernard
  • Website www.qiagen.com
  • Headquarter Netherlands
  • FIGI UNKNOWN
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
23.18
Price to sales ratio
4.79
Dividends per share
0.25
Dividend yield %
0.56

Qiagen N.V

QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer.

News